
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxNUFQtV0RDbnBtaDFCME13bGhLZU9TN2JhVVl5dFVlVS0tVGI4YkU5ZGRCb2FjYTVCcXJ5aHZrcGNzQmtlN3ZMc1VsMEdqTzFYN0tKWjhEc2NBWE5QSjlCcGhndTNzRHQ0dHROcW1kTS1XdldVazBpZzBwd2w2Wk93cVVDUHp1T19OZ2N4eDBScUQtaUxFNnBiWTFLend1dGM?oc=5" target="_blank">FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps</a>&nbsp;&nbsp;<font color="#6f6f6f">PharmTech.com</font>
